Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957.

Identifieur interne : 000195 ( PubMed/Corpus ); précédent : 000194; suivant : 000196

Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957.

Auteurs : Claudia Pappas ; Karthik Viswanathan ; Aarthi Chandrasekaran ; Rahul Raman ; Jacqueline M. Katz ; Ram Sasisekharan ; Terrence M. Tumpey

Source :

RBID : pubmed:20574518

English descriptors

Abstract

Influenza viruses of the H2N2 subtype have not circulated among humans in over 40 years. The occasional isolation of avian H2 strains from swine and avian species coupled with waning population immunity to H2 hemagglutinin (HA) warrants investigation of this subtype due to its pandemic potential. In this study we examined the transmissibility of representative human H2N2 viruses, A/Albany/6/58 (Alb/58) and A/El Salvador/2/57 (ElSalv/57), isolated during the 1957/58 pandemic, in the ferret model. The receptor binding properties of these H2N2 viruses was analyzed using dose-dependent direct glycan array-binding assays. Alb/58 virus, which contains the 226L/228S amino acid combination in the HA and displayed dual binding to both alpha 2,6 and alpha 2,3 glycan receptors, transmitted efficiently to naïve ferrets by respiratory droplets. Inefficient transmission was observed with ElSalv/57 virus, which contains the 226Q/228G amino acid combination and preferentially binds alpha 2,3 over alpha 2,6 glycan receptors. However, a unique transmission event with the ElSalv/57 virus occurred which produced a 226L/228G H2N2 natural variant virus that displayed an increase in binding specificity to alpha 2,6 glycan receptors and enhanced respiratory droplet transmissibility. Our studies provide a correlation between binding affinity to glycan receptors with terminal alpha 2,6-linked sialic acid and the efficiency of respiratory droplet transmission for pandemic H2N2 influenza viruses.

DOI: 10.1371/journal.pone.0011158
PubMed: 20574518

Links to Exploration step

pubmed:20574518

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957.</title>
<author>
<name sortKey="Pappas, Claudia" sort="Pappas, Claudia" uniqKey="Pappas C" first="Claudia" last="Pappas">Claudia Pappas</name>
<affiliation>
<nlm:affiliation>Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Viswanathan, Karthik" sort="Viswanathan, Karthik" uniqKey="Viswanathan K" first="Karthik" last="Viswanathan">Karthik Viswanathan</name>
</author>
<author>
<name sortKey="Chandrasekaran, Aarthi" sort="Chandrasekaran, Aarthi" uniqKey="Chandrasekaran A" first="Aarthi" last="Chandrasekaran">Aarthi Chandrasekaran</name>
</author>
<author>
<name sortKey="Raman, Rahul" sort="Raman, Rahul" uniqKey="Raman R" first="Rahul" last="Raman">Rahul Raman</name>
</author>
<author>
<name sortKey="Katz, Jacqueline M" sort="Katz, Jacqueline M" uniqKey="Katz J" first="Jacqueline M" last="Katz">Jacqueline M. Katz</name>
</author>
<author>
<name sortKey="Sasisekharan, Ram" sort="Sasisekharan, Ram" uniqKey="Sasisekharan R" first="Ram" last="Sasisekharan">Ram Sasisekharan</name>
</author>
<author>
<name sortKey="Tumpey, Terrence M" sort="Tumpey, Terrence M" uniqKey="Tumpey T" first="Terrence M" last="Tumpey">Terrence M. Tumpey</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20574518</idno>
<idno type="pmid">20574518</idno>
<idno type="doi">10.1371/journal.pone.0011158</idno>
<idno type="wicri:Area/PubMed/Corpus">000195</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000195</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957.</title>
<author>
<name sortKey="Pappas, Claudia" sort="Pappas, Claudia" uniqKey="Pappas C" first="Claudia" last="Pappas">Claudia Pappas</name>
<affiliation>
<nlm:affiliation>Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Viswanathan, Karthik" sort="Viswanathan, Karthik" uniqKey="Viswanathan K" first="Karthik" last="Viswanathan">Karthik Viswanathan</name>
</author>
<author>
<name sortKey="Chandrasekaran, Aarthi" sort="Chandrasekaran, Aarthi" uniqKey="Chandrasekaran A" first="Aarthi" last="Chandrasekaran">Aarthi Chandrasekaran</name>
</author>
<author>
<name sortKey="Raman, Rahul" sort="Raman, Rahul" uniqKey="Raman R" first="Rahul" last="Raman">Rahul Raman</name>
</author>
<author>
<name sortKey="Katz, Jacqueline M" sort="Katz, Jacqueline M" uniqKey="Katz J" first="Jacqueline M" last="Katz">Jacqueline M. Katz</name>
</author>
<author>
<name sortKey="Sasisekharan, Ram" sort="Sasisekharan, Ram" uniqKey="Sasisekharan R" first="Ram" last="Sasisekharan">Ram Sasisekharan</name>
</author>
<author>
<name sortKey="Tumpey, Terrence M" sort="Tumpey, Terrence M" uniqKey="Tumpey T" first="Terrence M" last="Tumpey">Terrence M. Tumpey</name>
</author>
</analytic>
<series>
<title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint>
<date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Birds</term>
<term>Disease Outbreaks</term>
<term>Erythrocytes (immunology)</term>
<term>Ferrets</term>
<term>Hemagglutination</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus (genetics)</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus (metabolism)</term>
<term>Humans</term>
<term>Influenza A Virus, H2N2 Subtype (genetics)</term>
<term>Influenza A Virus, H2N2 Subtype (isolation & purification)</term>
<term>Influenza A Virus, H2N2 Subtype (metabolism)</term>
<term>Influenza in Birds (transmission)</term>
<term>Influenza in Birds (virology)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (transmission)</term>
<term>Influenza, Human (virology)</term>
<term>Male</term>
<term>Microarray Analysis</term>
<term>Models, Molecular</term>
<term>Mutation</term>
<term>Polysaccharides (metabolism)</term>
<term>Protein Conformation</term>
<term>Receptors, Virus (chemistry)</term>
<term>Receptors, Virus (metabolism)</term>
<term>Respiration</term>
<term>Seasons</term>
<term>Substrate Specificity</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Receptors, Virus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Hemagglutinin Glycoproteins, Influenza Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Influenza A Virus, H2N2 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Erythrocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Influenza A Virus, H2N2 Subtype</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Hemagglutinin Glycoproteins, Influenza Virus</term>
<term>Influenza A Virus, H2N2 Subtype</term>
<term>Polysaccharides</term>
<term>Receptors, Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en">
<term>Influenza in Birds</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Influenza in Birds</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Birds</term>
<term>Disease Outbreaks</term>
<term>Ferrets</term>
<term>Hemagglutination</term>
<term>Humans</term>
<term>Male</term>
<term>Microarray Analysis</term>
<term>Models, Molecular</term>
<term>Mutation</term>
<term>Protein Conformation</term>
<term>Respiration</term>
<term>Seasons</term>
<term>Substrate Specificity</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Influenza viruses of the H2N2 subtype have not circulated among humans in over 40 years. The occasional isolation of avian H2 strains from swine and avian species coupled with waning population immunity to H2 hemagglutinin (HA) warrants investigation of this subtype due to its pandemic potential. In this study we examined the transmissibility of representative human H2N2 viruses, A/Albany/6/58 (Alb/58) and A/El Salvador/2/57 (ElSalv/57), isolated during the 1957/58 pandemic, in the ferret model. The receptor binding properties of these H2N2 viruses was analyzed using dose-dependent direct glycan array-binding assays. Alb/58 virus, which contains the 226L/228S amino acid combination in the HA and displayed dual binding to both alpha 2,6 and alpha 2,3 glycan receptors, transmitted efficiently to naïve ferrets by respiratory droplets. Inefficient transmission was observed with ElSalv/57 virus, which contains the 226Q/228G amino acid combination and preferentially binds alpha 2,3 over alpha 2,6 glycan receptors. However, a unique transmission event with the ElSalv/57 virus occurred which produced a 226L/228G H2N2 natural variant virus that displayed an increase in binding specificity to alpha 2,6 glycan receptors and enhanced respiratory droplet transmissibility. Our studies provide a correlation between binding affinity to glycan receptors with terminal alpha 2,6-linked sialic acid and the efficiency of respiratory droplet transmission for pandemic H2N2 influenza viruses.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">20574518</PMID>
<DateCompleted>
<Year>2010</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>5</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2010</Year>
<Month>Jun</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957.</ArticleTitle>
<Pagination>
<MedlinePgn>e11158</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0011158</ELocationID>
<Abstract>
<AbstractText>Influenza viruses of the H2N2 subtype have not circulated among humans in over 40 years. The occasional isolation of avian H2 strains from swine and avian species coupled with waning population immunity to H2 hemagglutinin (HA) warrants investigation of this subtype due to its pandemic potential. In this study we examined the transmissibility of representative human H2N2 viruses, A/Albany/6/58 (Alb/58) and A/El Salvador/2/57 (ElSalv/57), isolated during the 1957/58 pandemic, in the ferret model. The receptor binding properties of these H2N2 viruses was analyzed using dose-dependent direct glycan array-binding assays. Alb/58 virus, which contains the 226L/228S amino acid combination in the HA and displayed dual binding to both alpha 2,6 and alpha 2,3 glycan receptors, transmitted efficiently to naïve ferrets by respiratory droplets. Inefficient transmission was observed with ElSalv/57 virus, which contains the 226Q/228G amino acid combination and preferentially binds alpha 2,3 over alpha 2,6 glycan receptors. However, a unique transmission event with the ElSalv/57 virus occurred which produced a 226L/228G H2N2 natural variant virus that displayed an increase in binding specificity to alpha 2,6 glycan receptors and enhanced respiratory droplet transmissibility. Our studies provide a correlation between binding affinity to glycan receptors with terminal alpha 2,6-linked sialic acid and the efficiency of respiratory droplet transmission for pandemic H2N2 influenza viruses.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pappas</LastName>
<ForeName>Claudia</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Viswanathan</LastName>
<ForeName>Karthik</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chandrasekaran</LastName>
<ForeName>Aarthi</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Raman</LastName>
<ForeName>Rahul</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Katz</LastName>
<ForeName>Jacqueline M</ForeName>
<Initials>JM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sasisekharan</LastName>
<ForeName>Ram</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tumpey</LastName>
<ForeName>Terrence M</ForeName>
<Initials>TM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>U54 GM062116</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54 GM62116</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2010</Year>
<Month>06</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019267">Hemagglutinin Glycoproteins, Influenza Virus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011134">Polysaccharides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001717" MajorTopicYN="N">Birds</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004912" MajorTopicYN="N">Erythrocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005289" MajorTopicYN="N">Ferrets</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006384" MajorTopicYN="N">Hemagglutination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019267" MajorTopicYN="N">Hemagglutinin Glycoproteins, Influenza Virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053121" MajorTopicYN="N">Influenza A Virus, H2N2 Subtype</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005585" MajorTopicYN="N">Influenza in Birds</DescriptorName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D046228" MajorTopicYN="N">Microarray Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011134" MajorTopicYN="N">Polysaccharides</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012119" MajorTopicYN="N">Respiration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013379" MajorTopicYN="N">Substrate Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2010</Year>
<Month>01</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2010</Year>
<Month>05</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2010</Year>
<Month>6</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2010</Year>
<Month>6</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2010</Year>
<Month>11</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">20574518</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0011158</ArticleId>
<ArticleId IdType="pmc">PMC2888575</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Nature. 2006 Mar 23;440(7083):435-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16554799</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2006 Jan;12(1):34-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16494714</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12121-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16880383</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2007 Feb 2;315(5812):655-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17272724</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Jul;81(13):6890-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17459930</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20949-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18093945</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Biotechnol. 2008 Jan;26(1):107-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18176555</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2800-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18287068</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2008 May 27;105(21):7558-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18508975</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2008;3(8):e2923</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18698430</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2009 Jan;5(1):e1000252</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19119420</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3366-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19211790</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2009 Jul 10;325(5937):197-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19465683</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17175-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19805083</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Feb;84(4):1715-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20007271</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 1999 Dec;80 ( Pt 12):3167-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10567648</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bull World Health Organ. 1999;77(10):820-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10593030</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2000 Sep;74(18):8502-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10954551</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2003 Jul;70(3):391-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12767002</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2004 Oct 10;328(1):101-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15380362</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1989 Nov;63(11):4603-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2795713</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1989 Nov;173(1):317-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2815586</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbiol Rev. 1992 Mar;56(1):152-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1579108</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1993 Jun;194(2):781-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7684877</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1994 Nov 15;205(1):17-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7975212</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1997 Jun 23;233(1):224-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9201232</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 1998 Jul;178(1):53-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9652423</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1998 Sep;72(9):7367-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9696833</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Mar;79(5):2814-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15709000</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Sep;79(17):11533-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16103207</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Sep;79(18):11788-800</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16140756</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Glycoconj J. 2006 Feb;23(1-2):93-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16575526</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000195 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000195 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:20574518
   |texte=   Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:20574518" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a H2N2V1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021